Citations 1
Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+ Year Results of a 5-year, Open-label Treatment Period (1203)
Silberstein, Stephen D., Xue, Fei , Zhang, Feng, Cheng, Sunfa , Mikol, Daniel D., Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng
Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available
